ISO 14155:2019 … Changes to Expect

by | Sep 13, 2019 | 510k, FDA, ISO, Medical Devices, Quality Systems, Regulatory

ISO 14155 [Clinical investigation of medical devices for human subjects – Good clinical practice], as the name suggests, addresses good clinical practices for all pre- and post-market clinical investigations that determine the safety and performance of medical devices. The final publication of the 3rd edition of ISO 14155 is coming soon in 2019, with some key changes that manufacturers should consider.

Some key changes that will build upon the current edition of 14155:2011 is the inclusion of more vigorous risk management requirements across the whole lifecycle of clinical investigations. ISO 14155:2019 will closely tie risk management practices from ISO 14971 into all required clinical investigation processes. Some other notable changes to the standard in the upcoming 3rd edition include:

  • A summary section of GCP principles
  • Inclusion of guidance for clinical quality management
  • Inclusion of risk-based monitoring
  • Guidance on study design and statistical considerations
  • Increased clarity on how to apply the standard to different clinical development stages
  • Guidance on clinical investigation audits
  • The requirement of specific medical expertise in clinical investigation planning1

Currently, the revision is in the approval phase and being identified as ISO/FDIS 14155 because it is the final draft before publication, which is when it will start being identified as ISO 14155:2019. At this point the revision has been voted on by industry, technical, and regulatory experts and the next steps are approval for publication, which will turn the draft into an international standard.2

Have any questions about clinical investigations for your medical device or need help complying with international standards? Contact us at 248-987-4497 or email:

1ISO (n.d.) ISO/DIS 14155(en) retrieved on 09/10/2019 from

2ISO (n.d.) ISO/FDIS 14155 General Information retrieved on 09/10/2019 from

Emma International

Emma International

More Resources

Change Management And Control

Change Management And Control

One of the biggest and most important aspects of quality management is a system to monitor changes and how they impact the product. Change management is an approach for changing processes or products in a way which adheres to regulatory standards by ensuring stability and consistency throughout processes. It applies across all changes within a process and throughout an entire products life cycle.
Aseptic Technique and Gowning

Aseptic Technique and Gowning

One of the most common techniques to prevent contamination of products and reduce quality impacts in the pharmaceutical industry is called aseptic gowning. Humans are the biggest sources of microbial contamination in cleanroom environments and therefore proper gowning procedures are essential to ensuring product quality. Proper training, education, hygiene, qualification, and authorization must be put in place and be required for entry to all clean room environments...
Importance of Pharmaceutical GMP

Importance of Pharmaceutical GMP

Having high quality standards is vital to any organization but is even more essential in the pharmaceutical industry. Practices that are governed by these standards are commonly called Good Manufacturing Practices (GMP) and ensure consistent and controlled production of products. These practices govern all aspects and procedures within production and provide documented proof that procedures are consistently followed during the manufacturing processes every time products are made. They are designed to minimize risks throughout the manufacturing process that are not able to be eliminated in final product testing so that pharmaceuticals are safe for use...

Ready to learn more about working with us?

Pin It on Pinterest

Share This